Abens J, Westlind A, Bartfai T
Peptides. 1984 Mar-Apr;5(2):375-7. doi: 10.1016/0196-9781(84)90237-7.
Chronic atropine treatment (14 days, 20 mg X day-1 X kg-1 SC) caused a 75% increase in the number of VIP receptors in the rat cerebral cortex. The affinity of these receptors for 125I-VIP was not altered significantly by the atropine treatment. The same treatment led to a 20% decrease in VIP tissue levels. Muscarinic receptor number was also increased by 26%. The results indicate that interactions between VIP- and muscarinic receptors may be of importance in the rat cerebral cortex.
慢性阿托品治疗(14天,20毫克/天/千克,皮下注射)使大鼠大脑皮层中血管活性肠肽(VIP)受体数量增加了75%。阿托品治疗并未显著改变这些受体对125I-VIP的亲和力。相同的治疗导致VIP组织水平下降了20%。毒蕈碱受体数量也增加了26%。结果表明,VIP受体与毒蕈碱受体之间的相互作用可能在大鼠大脑皮层中具有重要意义。